Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[A CASE OF PROSTATE CANCER COMPLICATED BY PELVIC INSUFFICIENCY FRACTURES].

Hinyokika kiyo. Acta urologica Japonica·2026
Same author

A targeted combination therapy achieves effective pancreatic cancer regression and prevents tumor resistance.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Refractory Tunnel Infections Caused by Multidrug-Resistant Mycobacterium abscessus Requiring Peritoneal Dialysis Catheter Removal.

Cureus·2026
Same author

Out of Nucleus: Serine 727 Phosphorylation Orchestrates Non-Canonical STAT3 Functions-Relevance to Triple-Negative Breast Cancer.

International journal of molecular sciences·2026
Same author

Sulfonyl Anthranilic Acid Analogues Display Pan-Serotype Anti-Dengue Activity by Downregulating the Expression of Ribosomal Proteins Encoded by 5'-Terminal Oligopyrimidine Motif-Containing mRNA.

Journal of medicinal chemistry·2026
Same author

GPR146 in adipose tissue drives adipose-liver crosstalk and promotes hepatic steatosis in mice.

Nature communications·2026

Related Experiment Video

Updated: Jul 5, 2026

Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes
09:40

Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes

Published on: September 28, 2018

SHPS-1/SIRP1alpha contributes to interleukin-6 signalling.

Radoslaw M Sobota1, Pia J Müller, Christina Khouri

  • 1Department of Biochemistry, RWTH Aachen University, Pauwelsstrasse 30, D-52074 Aachen, Germany.

Cellular Signalling
|May 3, 2008
PubMed
Summary

Signal regulatory protein alpha (SIRP1alpha) influences interleukin-6 (IL-6) signaling by regulating SHP2 phosphorylation. This balance impacts ERK and STAT3 activation, crucial for cell responses in diseases.

More Related Videos

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Published on: July 17, 2020

Related Experiment Videos

Last Updated: Jul 5, 2026

Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes
09:40

Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes

Published on: September 28, 2018

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Published on: July 17, 2020

Area of Science:

  • Cellular signaling
  • Immunology
  • Molecular biology

Background:

  • Signal regulatory protein alpha (SIRP1alpha/SHPS-1) is a transmembrane glycoprotein involved in growth factor and cell adhesion signaling.
  • The role of SIRP1alpha in interleukin-6 (IL-6) type cytokine signaling remains largely unexplored.

Purpose of the Study:

  • To investigate the contribution of SIRP1alpha to IL-6 type cytokine signaling.
  • To elucidate the mechanism by which SIRP1alpha modulates IL-6 induced cellular responses.

Main Methods:

  • Utilized mouse embryonic fibroblasts (MEFs) with varying SIRP1alpha expression (wild-type and deficient).
  • Analyzed protein tyrosine phosphatase SHP2 phosphorylation, ERK1/2 activation, and STAT3 activation/phosphorylation.
  • Assessed STAT3-dependent gene induction in response to IL-6 stimulation.

Main Results:

  • SIRP1alpha binds SHP2 in an IL-6 stimulation-dependent manner.
  • SIRP1alpha deficiency enhances SHP2 phosphorylation but delays STAT3 activation and reduces STAT3-dependent gene induction.
  • SIRP1alpha counteracts SHP2 phosphorylation, influencing ERK activation and STAT3 transactivation.

Conclusions:

  • SIRP1alpha plays a critical role in modulating IL-6 signaling pathways.
  • The findings highlight SIRP1alpha's function in balancing MAPK and STAT3 activation in response to IL-6.
  • Dysregulation of this balance is implicated in autoimmune diseases, inflammatory conditions, and cancer.